Velorum Therapeutics Analysis
What is Velorum Therapeutics?
Velorum Therapeutics develops innovative therapies targeting heme biology to address unmet medical needs in diseases like porphyrias and cancer.
Employees
3
Founded
2023
Revenue
<$5M
Product Features & Capabilities
- cancer therapies targeting metabolic vulnerabilities, innovative treatments for porphyrias, drugs that disrupt tumor metabolism, therapies that unlock the biology of heme
Who are the founders of Velorum Therapeutics
PM
Pouya Modareszadeh
Co-Founder & CEO
PM
Parsa Modareszadeh
Co-Founder and President
Market Focus
Velorum Therapeutics primarily focuses on the biotechnology industry, specifically developing innovative therapies targeting the biology of heme to address unmet medical needs in diseases such as porphyrias and cancer.
Investors
- Y Combinator
- Ritual Capital
- Metaplanet Holdings
- Transpose Platform Management
Business Model
Bootstrapped revenue model focusing on innovative therapies and strategic funding rounds.
Competitors Overview
Velorum Therapeutics operates in a niche market focused on developing therapies that target heme biology, particularly for conditions like porphyrias and cancer. Its main competitors include:
- Disc Medicine: This company is developing therapies for hematologic diseases, including erythropoiet
See something that needs updating? Suggest edits to this profile.